Chitosan is a natural biopolymer that is synthesized in the outer skeleton of shellfish such as lobster, shrimp, and crab. This biopolymer is derived from chitin through a process of deacetylation, which converts it into chitosan. It exhibits a myriad of properties such as biocompatibility, biodegradability, antimicrobial activity, and antioxidant properties, which make suitable for use in a wide range of applications; for instance, it used in dietary supplements, food packaging, and in wound care.
The growth of the global chitosan market is majorly driven by surge in demand for chitosan from various industries, including healthcare, pharmaceuticals, food & beverages, and agriculture. Chitosan is non-toxic and compatible with human tissues, making it suitable for medical and pharmaceutical applications, including wound dressings, drug delivery systems, and tissue engineering. Its antimicrobial, biocompatible, and water retention properties aid in wound healing and skin care. For instance, according to the 2018 estimates of the European Centre for Disease Prevention and Control (ECDC), nearly 33,000 individuals die every year due to infection with antibiotic-resistant bacteria. This has necessitated the development of developing new antimicrobials from natural and synthetic molecules, which, in turn, has fostered the demand for chitosan in the medical sector. In addition, chitosan's exhibits the ability to bind with contaminants, including heavy metals and dyes, which makes it a sustainable choice for water treatment. In addition, as the world’s food demand is aligning with the increasing global population, the need for sustainable agricultural practices has increased notably. Chitosan serves as a sustainable alternative to conventional agrochemicals, thus fostering the adoption of safer agricultural practices. This is attributed to the fact that chitosan-based formulations can effectively control pests and diseases, reduce the need for chemical pesticides, and improve crop yields, which boosts its demand in the agricultural sector.
Some studies claim that chitosan assists in weight loss and lowers cholesterol levels by eliminating fat and cholesterol from the body instead of allowing the body to absorb them. However, current studies do not support this claim. Clinical trials conducted in the early 2000s found that chitosan did not facilitate fat excretion in stool, and there is no indication that it traps fat. Thus, such discrepancies hamper the demand for chitosan supplements, which significantly hampers the growth of the global market. High production costs of chitosan further acts as a key deterrent factor of the global market. Contrarily, surge in demand for chitosan as a natural preservative to extend the shelf life of food products due to its antimicrobial properties. Thus, manufacturers are focusing on the development of edible chitosan-based edible films and coatings to prevent the spoilage of food products, which is expected to offer remunerative opportunities for the growth of the market during the forecast period.
The chitosan market is segmented into source, application, and region. By source, the market is classified into shrimp, squid, crab, krill, and others. On the basis of application, it is divided into water treatment, biomedical & pharmaceutical, cosmetics, food & beverage, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By source, the shrimp segment held the highest market share in 2023 and is likely to retain its dominance by 2033.Depending on application, the water treatment segment was the major shareholder in 2023 and is expected to continue the same trend during the forecast period.
Region wise, Asia-Pacific is expected to experience the fastest growth during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global chitosan market include PRIMEX EHF, ADVANCED BIOPOLYMERS AS, Panvo Organics Pvt Ltd., Heppe Medical Chitosan GmbH, G.T.C. Bio Corporation, Kitozyme S.A., Novamatrix, Agratech International, Inc., Golden-Shell Pharmaceutical Co. Ltd., and Qingdao Yunzhou Biochemistry Co. Ltd. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Analysis of raw material in a product (by %)
- Manufacturing Capacity
- Product Benchmarking / Product specification and applications
- Product Life Cycles
- Supply Chain Analysis & Vendor Margins
- Upcoming/New Entrant by Regions
- Average Consumer Expenditure
- Go To Market Strategy
- Market share analysis of players by products/segments
- New Product Development/ Product Matrix of Key Players
- Pain Point Analysis
- Regulatory Guidelines
- Strategic Recommendations
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
- Import Export Analysis/Data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
- List of customers/consumers/raw material suppliers- value chain analysis
- Market share analysis of players at global/region/country level
- Per Capita Consumption Trends
- SWOT Analysis
- Volume Market Size and Forecast
Key Market Segments
By Source
- Shrimp
- Squid
- Crab
- Krill
- Others
By Application
- Water treatment
- Biomedical and Pharmaceutical
- Cosmetics
- Food and Beverage
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- PRIMEX EHF
- ADVANCED BIOPOLYMERS AS
- Panvo Organics Pvt Ltd.
- Heppe Medical Chitosan GmbH
- G.T.C. Bio Corporation
- Kitozyme S.A.
- Novamatrix
- Agratech International, Inc.
- Golden-Shell Pharmaceutical Co. Ltd.
- Qingdao Yunzhou Biochemistry Co. Ltd.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Companies Mentioned
Key Market Players in the Chitosan Market include:- PRIMEX EHF
- ADVANCED BIOPOLYMERS AS
- Panvo Organics Pvt Ltd.
- Heppe Medical Chitosan GmbH
- G.T.C. Bio Corporation
- Kitozyme S.A.
- Novamatrix
- Agratech International, Inc.
- Golden-Shell Pharmaceutical Co. Ltd.
- Qingdao Yunzhou Biochemistry Co. Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 300 |
Published | July 2024 |
Forecast Period | 2023 - 2033 |
Estimated Market Value ( USD | $ 7.8 billion |
Forecasted Market Value ( USD | $ 42.8 billion |
Compound Annual Growth Rate | 18.7% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |